tirzepatide and plan b Compound Tirzepatide for Medical Weight Loss

Semaglutide may be preferred as a first-line agent in patients with milder PCOS phenotypes, lower BMI, or good baseline GLP-1 sensitivity

In the PIONEER 5 trial, oral semaglutide demonstrated effectiveness in T2DM patients with moderate renal impairment, thereby offering a new treatment option [64]

Since GLP-1 medications slow stomach emptying and can reduce appetite, thirst cues may be blunted, making it easier to unintentionally underdrink, says McGowan

The 2.5 mg dose is considered the starter dose the one patients take first before they move up to higher doses until they reach their so-called maintenance doses